Menu
BW CFO World
Community for Finance Professionals, Consultants and allied businesses
  • Home
  • News
  • Videos
  • Articles
    • Credit & Capital
    • Economic Trends
    • Financial Compliance
    • Financial Leadership
    • Financial Management
    • Financial Reporting
    • Financial Strategy
    • Risk Management
    • Taxation
  • Featured
  • Nominate for Awards
Close Menu
indian rupee
October 19, 2022

Piramal Pharma Lists On Stock Exchanges After Demerger

Urvi Srivastava Financial Reporting demerger, pharma, Piramal, SEBI, stock exchange

Last week, Piramal Pharma said that it has received an approval from the Securities and Exchange Board of India (Sebi) to list shares on the stock exchange

Shares of Piramal Pharma (PPL) were listed on stock exchanges on Wednesday after a demerger from Piramal Enterprises (PEL).

The shares were listed at Rs 201.8 apiece on the BSE, while on the NSE trading started at Rs 200 per share.

Last week, Piramal Pharma said that it has received an approval from the Securities and Exchange Board of India (Sebi) to list shares on the stock exchange.

NCLT had approved the demerger of Piramal Enterprises’ Pharma business in August.

As part of the demerger scheme, four full paid-up equity shares of PPL of Rs 10 each to be issued to PEL shareholders for every one fully paid-up equity share in PEL with a face value of Rs 2 each held by them.

The demerger from PEL will firmly empower PPL to be future ready and enable it to independently pursue its growth strategies with sharper focus and identity, the company said.

The board of the company had approved the demerger of the Pharma business and the simplification of the corporate structure in October 2021.

Piramal Enterprises shares started trading ex-pharma business on Tuesday, 30 August, 2022. The company fixed September 1, as the record date for the demerger of Piramal Pharma.

Urvi Shrivastav

→ Urvi Shrivastav

Centre To Start Rs 500 Cr Accelerator Programme To Enhance Agri Startups L&T Technology Services Reports 24% YoY Growth In Q2 FY23

Related Posts

Anurag Mishra CFO

Financial Reporting

JW Marriott New Delhi Appoints Anurag Mishra as Director of Finance

economy

Financial Reporting

Economy Remains Steady In Recent Months: PHD Chamber

20220714_125227

Financial Reporting

Infosys Reports Strong Growth In Q3, Revenues Jump To Rs 38,318 Cr

Selected Stories

  • Anurag Mishra CFOJW Marriott New Delhi Appoints Anurag Mishra as Director of Finance

    Read more

  • 1678170556_zXCK41_CFOBest CFO & Finance Strategy Awards: Navigating Through Uncertain Macroeconomic Environment

    Read more

  • economyEconomy Remains Steady In Recent Months: PHD Chamber

    Read more

  • 20220714_125227Infosys Reports Strong Growth In Q3, Revenues Jump To Rs 38,318 Cr

    Read more

  • 20211201_100953-1Tech Mahindra, Microsoft Collaborate To Deliver Cloud-powered 5G Core Network Modernisation For Telcos

    Read more

Movements

  • zUah2lDb_400x400Deloitte India Named Romal Shetty As CEO For Four-Year Term
  • cfo imageVishnuhari Pareek Named As Head Of Finance At Arkam Ventures
  • thumbnail_Sidharth1Siddharth Sehgal Is New CFO Of BeatO
  • Business men giving a handshake. Business conceptRamamurthy Becomes MD, CEO of BSE, SEBI approves appointment
  • 1554629557880Arvind Agarwal Resigns Nykaa, Joins PayU India As CFO

Categories

  • Accounting
  • CFO Stance
  • Credit & Capital
  • Economic Trends
  • Featured
  • Financial Compliance
  • Financial Leadership
  • Financial Management
  • Financial Reporting
  • Financial Strategy
  • Financial Technologies
  • Global News
  • Interview
  • Movements
  • Risk Management
  • Taxation

Recent Comments

    Back To Top
    BW CFO World
    • Home
    • News
    • Videos
    • Articles
      • Credit & Capital
      • Economic Trends
      • Financial Compliance
      • Financial Leadership
      • Financial Management
      • Financial Reporting
      • Financial Strategy
      • Risk Management
      • Taxation
    • Featured
    • Nominate for Awards
    © Copyright BW BUSINESSWORLD 2018. All Rights Reserved.